Discontinuing the CCB and switching to an alternative antihypertensive therapy will resolve the edema. Peripheral edema is an uncommon problem in patients with untreated hypertension because local ...
There have been inconsistent findings when switching from one dihydropyridine CCB to another or when switching to different formulations of the same drug to lessen or resolve peripheral edema.
The FDA has approved Sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and dexamethasone for transplant-ineligible, newly diagnosed multiple myeloma.
To ascertain the influence of colloid osmotic (oncotic) and hydrostatic pressure on excess lymph and edema formation in congestive heart failure, a disorder characterized by generalized venous ...
The neck veins were not distended, and the liver was neither palpable nor tender. There was no peripheral edema. The heart was regular, with sounds of good quality, and there were no rubs or murmurs.